How Does Novozymes Company Segment and Target Its Market?

Novozymes targets global CPG giants and industrial formulators in Household Care to improve detergent efficacy and lower carbon/water footprints; this vertical helped drive demand within the 56% Planetary Health Biosolutions mix in 2024 and remains core to Novozymes market segmentation for scale clients.

Food and Beverage firms-bakeries, dairies, brewers-are served with enzyme solutions in the Food and Health Biosolutions pillar that accounted for 44% of 2024 sales, reflecting Novozymes target market focus on high-volume, process-improving customers.

Bioenergy customers are primarily ethanol plants in the US and Brazil, while Agriculture serves commercial growers and feed producers; both segments fit Novozymes segmentation by industry and application for volume and sustainability gains.

Post-2024 merger creating Novonesis expanded exposure to human health, a high-growth niche; overall Novozymes serves over 30 industries, reflecting enzyme company segmentation into primary and adjacent markets.

Novozymes is primarily B2B, serving enterprises and institutions-large CPGs, manufacturers, and agricultural firms-using account-based marketing and industry-specific targeting to win high-volume contracts and long-term partnerships.

The Household Care and broader Planetary Health pillar appears most important by revenue and strategic relevance, given its 56% share of 2024 sales and deep partnerships with top detergent manufacturers, driving repeat industrial demand.

Demand peaks in regions with strict decarbonization policy and heavy industry, where enzyme solutions cut emissions and process costs; this aligns with Novozymes market segmentation targeting sustainability-focused brands and industrial clients.

Organized retail growth in India and China drives laundry and baking enzyme demand, while Brazil fuels bioenergy and soil-health solutions-showing enzyme company segmentation by end-use application and geography.

Revenue mix in 2025: Europe ~35-40%, North America ~30-35%, Asia – Pacific ~25-30%. Novozymes dominates North American bioenergy, serving over 60% of corn ethanol plants, reflecting targeted biotech B2B targeting and commercial strength.

Emerging markets grew organically 15% in early 2025; India and China are highest upside for detergents and food enzymes, while Brazil remains critical for bioenergy-evidence of Novozymes geographic market targeting strategy and segmentation by customer needs.

Global key accounts now account for a majority of revenue, showing Novozymes target market focus on large manufacturers in detergents, food & beverage, and bioenergy. High account concentration confirms enzyme company segmentation toward enterprise B2B clients and industrial enzyme market leadership with a 48% global share in 2025.

Cross-selling of enzymes with newly integrated microbial cultures targets plant-based proteins and dairy alternatives, raising average deal sizes and margins. Management is directing R&D and commercial efforts at a €5 billion TAM for biological surfactants by 2026 and carbon-capture enzymatics, illustrating Novozymes marketing strategy to move up the value chain.

Technical co-development, embedded R&D partnerships, and precision fermentation integrations create meaningful switching costs and stickiness. Repeat demand is visible in multi-year contracts and pilot-to-scale pipelines, supporting high retention and deep account penetration in Novozymes segmentation by customer needs and application.

Customer mix validates strategic fit: strong enterprise focus, high-margin cross-sell, and resilient demand reduce exposure to industrial cyclicality. Professional judgment 2025/2026: with leadership in the industrial enzyme market and a clear pivot to precision fermentation, Novozymes is positioned to capture the biological transition in manufacturing; see Business Case History of Novozymes Company for context.